Capricor Therapeutics Inc (CAPR)

Nov 20, 2024

Capricor stock on watch after key EU designations (CAPR:NASDAQ) - Seeking Alpha

Nov 20, 2024

Nov 20, 2024

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency - The Manila Times

Nov 20, 2024

Nov 18, 2024

(CAPR) Proactive Strategies - Stock Traders Daily

Nov 18, 2024

Nov 18, 2024

Capricor Therapeutics shares rated Buy by Jones Trading, boosted by DMD-CM therapy - Investing.com Canada

Nov 18, 2024

Nov 18, 2024

HC Wainwright Brokers Increase Earnings Estimates for CAPR - MarketBeat

Nov 18, 2024

Nov 16, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) Short Interest Down 14.6% in October - MarketBeat

Nov 16, 2024

Nov 16, 2024

Is Capricor Therapeutics (CAPR) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Nov 16, 2024

Nov 15, 2024

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 15, 2024

Capricor Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

Capricor Therapeutics Inc (CAPR) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 14, 2024

10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey

Nov 14, 2024

Nov 14, 2024

Earnings call: Capricor outlines deramiocel's path to market for DMD treatment - Investing.com Canada

Nov 14, 2024

Nov 14, 2024

Capricor Therapeutics (NASDAQ:CAPR) Trading 7.3% Higher on Analyst Upgrade - MarketBeat

Nov 14, 2024

Nov 14, 2024

Cantor Fitzgerald Issues Positive Forecast for Capricor Therapeutics (NASDAQ:CAPR) Stock Price - MarketBeat

Nov 14, 2024

Nov 14, 2024

Decoding 12 Analyst Evaluations For Capricor Therapeutics - Benzinga

Nov 14, 2024

Nov 13, 2024

Capricor Therapeutics (CAPR) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 13, 2024

Nov 13, 2024

Capricor Therapeutics Advances with Strategic Expansions - TipRanks

Nov 13, 2024

Nov 13, 2024

Capricor: Q3 Earnings Snapshot - San Antonio Express-News

Nov 13, 2024

Nov 13, 2024

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times

Nov 13, 2024

Nov 13, 2024

Capricor Therapeutics earnings missed by $0.02, revenue fell short of estimates - Investing.com UK

Nov 13, 2024

Nov 12, 2024

CAPRCapricor Therapeutics Inc Latest Stock News & Market Updates - StockTitan

Nov 12, 2024

Nov 12, 2024

Capricor Therapeutics to Present Exosome Platform Updates - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Capricor's StealthX Platform Shows Promise in DMD Treatment, Shares New Data | CAPR Stock News - StockTitan

Nov 12, 2024

Nov 09, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) Receives $24.67 Average Price Target from Analysts - Defense World

Nov 09, 2024

Nov 08, 2024

Objective long/short (CAPR) Report - Stock Traders Daily

Nov 08, 2024

Nov 07, 2024

Capricor Therapeutics (NASDAQ:CAPR) Stock Price Up 10.6%What's Next? - MarketBeat

Nov 07, 2024

Nov 07, 2024

Is Capricor Therapeutics (CAPR) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

Duchenne Muscular Dystrophy (DMD) Therapeutics Market to Grow by USD 4.37 Billion from 2024-2028, Driven by High Unmet Needs and AI-Powered Market EvolutionTechnavio - The Malaysian Reserve

Nov 07, 2024

Nov 06, 2024

Capricor Therapeutics (CAPR) Scheduled to Post Earnings on Wednesday - MarketBeat

Nov 06, 2024

Nov 06, 2024

Capricor Therapeutics (NASDAQ:CAPR) Shares Pass Above Fifty Day Moving AverageTime to Sell? - MarketBeat

Nov 06, 2024

Nov 05, 2024

Earnings Preview: Capricor Therapeutics (CAPR) Q3 Earnings Expected to Decline - Yahoo Finance

Nov 05, 2024

Nov 05, 2024

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13 - The Manila Times

Nov 05, 2024

Nov 01, 2024

Capricor Therapeutics (CAPR) Faces 5% Drop Amid Industry Slump - GuruFocus.com

Nov 01, 2024

Oct 29, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) Short Interest Up 17.9% in October - MarketBeat

Oct 29, 2024

Oct 28, 2024

Capricor Therapeutics (NASDAQ:CAPR) Shares Down 3.3%Time to Sell? - MarketBeat

Oct 28, 2024

Oct 25, 2024

High Growth Tech Stocks to Watch in October 2024 - Simply Wall St

Oct 25, 2024

Oct 25, 2024

Here's What Could Help Capricor (CAPR) Maintain Its Recent Price Strength - Yahoo Finance

Oct 25, 2024

Oct 23, 2024

Capricor Therapeutics Options Trading: A Deep Dive into Market Sentiment - Benzinga

Oct 23, 2024

Oct 22, 2024

Piper Sandler Initiates Coverage of Capricor Therapeutics (CAPR) with Overweight Recommendation - MSN

Oct 22, 2024

Oct 22, 2024

Capricor Therapeutics (NASDAQ:CAPR) shareholder returns have been enviable, earning 685% in 5 years - Simply Wall St

Oct 22, 2024

Oct 21, 2024

Capricor Therapeutics initiated at Overweight by Piper Sandler - MSN

Oct 21, 2024

Oct 21, 2024

Capricor Therapeutics (NASDAQ:CAPR) Trading Up 4.3%Here's Why - MarketBeat

Oct 21, 2024

Oct 21, 2024

Piper Sandler Begins Coverage on Capricor Therapeutics (NASDAQ:CAPR) - MarketBeat

Oct 21, 2024

Oct 21, 2024

Capricor Therapeutics stock outlook driven by DMD drug potential, says Piper Sandler - Investing.com Canada

Oct 21, 2024

Oct 19, 2024

Cash raises for Inventiva, Akeso, Capricor - BioCentury

Oct 19, 2024

Oct 18, 2024

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - The Manila Times

Oct 18, 2024

Oct 18, 2024

Capricor Therapeutics Announces Closing of Underwritten - GlobeNewswire

Oct 18, 2024

Oct 18, 2024

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares - StockTitan

Oct 18, 2024

Oct 17, 2024

Form 424B5 CAPRICOR THERAPEUTICS, - StreetInsider.com

Oct 17, 2024

Oct 17, 2024

Capricor Therapeutics (NASDAQ:CAPR) Shares Gap DownHere's What Happened - MarketBeat

Oct 17, 2024